Literature DB >> 3191581

The relation between inhibition of glycolysis and stimulation of oxygen uptake due to glucagon in livers from rats in different metabolic conditions.

R B Bazotte1, J Constantin, N S Hell, E L Iwamoto, A Bracht.   

Abstract

The relation between the effects of glucagon on oxygen consumption and glycolysis in livers from rats under different metabolic conditions was examined. Respiration of substrate-free perfused livers with different glycolytic fluxes, induced by changes in the pattern of food intake, responds differently to the infusion of 1 nM glucagon. The increases in oxygen uptake caused by 1 nM glucagon correlate reasonably well with the absolute decreases in glycolysis. The degree of inhibition of glycolysis is approximately constant (58 per cent) for all metabolic conditions. When no recovery of glycolysis occurs upon cessation of glucagon infusion, the same happens with oxygen consumption, which remains stimulated. It is concluded that in livers with no appreciable biosynthetic activities, the action of glucagon on respiration and glycolysis may be interpreted in terms of an interaction of interpreted in terms of an interaction of cytosolic and mitochondrial ATP generating processes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191581     DOI: 10.1002/cbf.290060402

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  2 in total

1.  Glycogen levels and glycogen catabolism in livers from arthritic rats.

Authors:  Z Fedatto-Júnior; E L Ishii-Iwamoto; S M Caparroz-Assef; G E Vicentini; A Bracht; A M Kelmer-Bracht
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  Sustained Liver Glucose Release in Response to Adrenaline Can Improve Hypoglycaemic Episodes in Rats under Food Restriction Subjected to Acute Exercise.

Authors:  Lucas K R Babata; Maria M D Pedrosa; Rosângela F Garcia; Márcia V Peicher; Vilma Aparecida Ferreira de Godoi
Journal:  Int J Endocrinol       Date:  2014-02-27       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.